As SpaceX prepares to list on the Nasdaq in June, the early technology trend spotter walks through the story behind one of the most anticipated public offerings in years.
As SpaceX prepares to list on the Nasdaq in June, the early technology trend spotter walks through the story behind one of the most anticipated public offerings in years.
PITTSBURGH, June 3, 2026 /PRNewswire/ -- Wesco International (NYSE: WCC), a leading provider of business-to-business distribution, logistics services and supply chain solutions, announces its inclusion...
Between 2018 and 2023, Dr Ivan Puah treated over 550 cases, addressing unique challenges in Singapore's multi-ethnic population. His study included diverse case profiles....
James Altucher walks through what Starlink's expanding constellation signals about the company's future and why most investors haven't connected the dots.
James Altucher walks through what Starlink's expanding constellation signals about the company's future and why most investors haven't connected the dots.
Though polygraph ("lie detector") tests are too unreliable to be admissible in court, physicians may be forced to undergo them in Physician Health Programs
Saint Herblain (France), August 18, 2025 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced that Health Canada has granted marketing authorization for its single-dose vaccine, IXCHIQ®, for the prevention of disease caused by the chikungunya virus in individuals aged 12 years and older. This announcement adds to the adult marketing authorization already received in Canada1 and complements the adolescent label extension received in Europe in April 20252.
MIAMI, Aug. 15, 2025 /PRNewswire/ -- Knowledge-based assessments remain a foundation of medical education. However, leveraging these resources for learning requires detailed and verifiable...
Summer Appreciation Sales Offers 12% Off All Products
NEW YORK, Aug. 15, 2025 /PRNewswire/ -- BestQool , a pioneer manufacturer of home-use red light therapy...
Changes recommended in clinical trial design to include the voice of more people living with type 1 diabetes in evaluating therapy benefits
NEW YORK, Aug....